(Q52034065)

20 April 2018

title

Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma. (English)

1 reference

20 April 2018

1 reference

7

1 reference

20 April 2018

Dennis Chi

6

object named as

Dennis S Chi

1 reference

20 April 2018

author name string

Aliza L Leiser

1

1 reference

20 April 2018

Sibyl E Anderson

2

1 reference

20 April 2018

Daisuke Nonaka

3

1 reference

20 April 2018

Shaokun Chuai

4

1 reference

20 April 2018

Adam B Olshen

5

1 reference

20 April 2018

language of work or name

English

0 references

publication date

9 November 2005

1 reference

20 April 2018

published in

Gynecologic Oncology

1 reference

20 April 2018

volume

101

1 reference

20 April 2018

issue

1

1 reference

20 April 2018

page(s)

86-91

1 reference

20 April 2018

Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcoma.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.055

Evaluation of paclitaxel in previously treated leiomyosarcoma of the uterus: a gynecologic oncology group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.055

Uterine leiomyosarcoma: present management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.055

The role of apoptosis in gynaecological malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.055

p53 alterations in uterine leiomyosarcomas versus leiomyomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.055

Abnormalities of the p53 MDM2 and DCC genes in human leiomyosarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.055

Apoptosis - the p53 network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.055

Apoptosis and the expression of Bax and Bcl-2 in squamous cell carcinoma and adenocarcinoma of the uterine cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.055

Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.055

Correlation of bcl-2 oncoprotein immunohistochemical expression with proliferation index and histopathologic parameters in colorectal neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.055

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.055

High levels of expression of p27KIP1 and cyclin E in invasive primary malignant melanomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.055

Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.055

ErbB2 overexpression in human breast carcinoma is correlated with p21Cip1 up-regulation and tyrosine-15 hyperphosphorylation of p34Cdc2: poor responsiveness to chemotherapy with cyclophoshamide methotrexate, and 5-fluorouracil is associated with Erb

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.055

Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading (IRS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.055

Antitumor effect of bcl-2 antisense phosphorothioate oligodeoxynucleotides on human renal-cell carcinoma cells in vitro and in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.055

Ribozyme-mediated induction of apoptosis in human cancer cells by targeted repair of mutant p53 RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.055

Expression of drug resistance related proteins in sarcomas of the pulmonary artery and poorly differentiated leiomyosarcomas of other origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.055

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.055

WAF1, a potential mediator of p53 tumor suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.055

p27Kip1 induces drug resistance by preventing apoptosis upstream of cytochrome c release and procaspase-3 activation in leukemic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.055

Differential effects of cell cycle regulatory protein p21(WAF1/Cip1) on apoptosis and sensitivity to cancer chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.055

Immunohistochemical localization of p21(WAF1/CIP1) in normal, hyperplastic, and neoplastic uterine tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.055

CDK-inhibitors-associated kinase activity: a possible determinant of malignant potential in smooth muscle tumors of the external soft tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.055

Apoptosis in human uterine leiomyomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.055

Image cytometric bcl-2:bax and bcl-2:bcl-x ratios in invasive breast carcinoma: correlation with prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.055

Reduced expression of both Bax and Bcl-2 is independently associated with lymph node metastasis in human breast carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.055

Bax expression decreases significantly from primary tumor to metastasis in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.055

Decreased expression of Bax is correlated with poor prognosis in oral and oropharyngeal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.055

Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.055

Prognostic significance of bcl-2 expression in leiomyosarcoma of the uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.055

Analysis of p53/BAX in primary colorectal carcinoma: low BAX protein expression is a negative prognostic factor in UICC stage III tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.055

10.1016/J.YGYNO.2005.09.055

7 January 2021

Identifiers

DOI

1 reference

20 April 2018

PubMed ID

16289259

1 reference

20 April 2018